Author(s):
Pankaj Prashar, Pardeep Kumar, Ankita Sood, Anamika Gautam, Harmeet Kaur, Arvinder Kaur, Ruksaar Ebrahim, Shubham Sharma, Indu Melkani, Narendra Kumar Pandey, Bimlesh Kumar
Email(s):
bimlesh1Pharm@gmail.com , bimlesh.12474@lpu.co.in
DOI:
10.5958/0974-360X.2020.00931.2
Address:
Pankaj Prashar, Pardeep Kumar, Ankita Sood, Anamika Gautam, Harmeet Kaur, Arvinder Kaur, Ruksaar Ebrahim, Shubham Sharma, Indu Melkani, Narendra Kumar Pandey, Bimlesh Kumar*
School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India.
*Corresponding Author
Published In:
Volume - 13,
Issue - 11,
Year - 2020
Cite this article:
Pankaj Prashar, Pardeep Kumar, Ankita Sood, Anamika Gautam, Harmeet Kaur, Arvinder Kaur, Ruksaar Ebrahim, Shubham Sharma, Indu Melkani, Narendra Kumar Pandey, Bimlesh Kumar. Investigation of selected 13 FDA approved drugs for TRPV1 Antagonism using molecular docking: An insight application for the treatment of Neuronal pain. Research J. Pharm. and Tech. 2020; 13(11):5328-5332. doi: 10.5958/0974-360X.2020.00931.2